April's Latest News and updates from DrugBank
Welcome to this month's edition of the DrugBank Data Digest, where we bring you the latest insights and updates from the forefront of pharmaceutical research and innovation.
Is Generative AI The Future of Equitable Healthcare?
AI is reshaping the accessibility of social determinants of health in electronic health records, setting new standards for care. Learn how specialized AI models are significantly improving the identification of social determinants in health records, enabling more equitable patient care.
The Cost of Knowledge: Evaluating Open vs. Paid Data for Pharma
The decision between a free open source knowledge base and a paid knowledge base depends on what will best suit an organization's specific requirements, budget, and long-term goals. Learn how choosing the right data source can be a game-changer in the competitive landscape of drug discovery and development.
Shaping the Future: Eli Lilly's Role in the Weight Management Revolution
Eli Lilly projects up to $41.6 billion in revenue for 2024, fueled by innovative diabetes and obesity treatments. Competitors are racing to enter the market after seeing El Lilly’s huge success with Mounjaro. ?Read our analysis on what this means for the industry.?
领英推荐
The Race for Ozempic Alternatives: Unlocking the Future of Weight Loss Medication
As the popularity of Ozempic soars, the competition to uncover the next best in class weight management drugs is heating up. Check out our latest blog for a full rundown of the key players, emerging trends, and big predictions for 2024!
Vector Space Biosciences: Leading Innovation in Space Medicine with AI
Space's extreme conditions are unlocking new possibilities for tackling aging and diseases on Earth. See how space medicine is pioneering health solutions for both astronauts and earthbound patients alike.
Product Updates
DrugBank 6.0
Our latest update, DrugBank 6.0, was recently profiled in the January 5, 2024 issue of Nucleic Acids Research. The article highlights the myriad ways in which we have focused on making DrugBank not just a knowledgebase, but a vital partner in your healthcare research.